ERBA Diagnostics, Inc. (fka ERBA)

[clearsudden]

Stocks To Watch: ERBA Diagnostics Inc
By WallStreetAnalyzed · April 1, 2014 · No comments
Press Releases · ERBA Diagnostics Inc,

http://www.nismagazine.com/stocks-to-watch-erba-diagnostics-inc-and-novabay-pharmaceuticals-inc/1219817/


Technical’s for ERBA Diagnostics Inc (NYSEMKT:ERB) Share prices of the company rose by 8.9% and closed at $2.57 in the last trading session. Prices closed above 20 days EMA and 50 Days EMA of $2.59 and $2.69 with RSI of 47.63

ERBA Diagnostics Inc (NYSEMKT:ERB) postpones the release of Annual Report

ERBA Diagnostics Inc (NYSEMKT:ERB) who is engaged in developing diagnostic tests kit to customers in US and Italy, prices year to date had been trading more volatile. The company recently announced a 15 days delay in releasing its annual report for December 31, 2013. The company plans to file it with SEC on or before 15th of April 2014. The company claims unforeseen delays in consolidating its financials and footnotes attached to the same, which were due to the recent purchases of its two subsidiaries that were acquired by the company in the previous year, namely Drew Scientific Inc and JAS Diagnostic Inc. This delay is subject to approval of SEC under Section 13 or 15d of the Act. Following this announcement, the company also declared its annual meeting that is to be held on 20 May 2014.